Cheap cancer drug finally tested in humans

John Bayko writes: Mentioned on Slashdot a couple of years ago, the drug dichloroacetate (DCA) has finally finished its first clinical trial against brain tumours in humans. Drug companies weren't willing to test a drug they could not patent, so money was raised in the community through donations, auctions, and finally government support, but the study was still limited to five patients, showing extremely positive results in four of them. It also raises the question of where all the money donated to Canadian and other cancer societies, and especially the billions spent buying merchandise with little pink ribbons on it goes, if not to actual cancer research like this.